University of Minnesota develops cancer drug that helps dogs with hemangiosarcomaFebruary 14, 2017The University of Minnesota has announced the breakthrough trial of a new drug that improves survival rates in dogs diagnosed with a cancer called hemangiosarcoma (HSA). The research and results were published recently published in the journal of Molecular Cancer Therapeutics.
SPONSORED CONTENTSwitch to Triple Protection in One Monthly DoseSee the difference of triple protection with the one monthly chew. + Learn More